The type I collagen induction of MT1-MMP-mediated MMP-2 activation is repressed by αVβ3 integrin in human breast cancer cells

Albelda, 1990, Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression, Cancer Res., 50, 6757 Azzam, 1992, Collagen-induced activation of the M(r) 72,000 type IV collagenase in normal and malignant human fibroblastoid cells, Cancer Res., 52, 4540 Baciu, 2003, Membrane type-1 matrix metalloproteinase (MT1-MMP) processing of pro-alphav integrin regulates cross-talk between alphavbeta3 and alpha2beta1 integrins in breast carcinoma cells, Exp. Cell Res., 291, 167, 10.1016/S0014-4827(03)00387-2 Bafetti, 1998, Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells, J. Biol. Chem., 273, 143, 10.1074/jbc.273.1.143 Brooks, 1994, Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels, Cell, 79, 1157, 10.1016/0092-8674(94)90007-8 Brooks, 1995, Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin, J. Clin. Invest., 96, 1815, 10.1172/JCI118227 Brooks, 1996, Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3, Cell, 85, 683, 10.1016/S0092-8674(00)81235-0 Butler, 1998, The TIMP2 membrane type 1 metalloproteinase “receptor” regulates the concentration and efficient activation of progelatinase A. A kinetic study, J. Biol. Chem., 273, 871, 10.1074/jbc.273.2.871 Cheresh, 1991, Structure, function and biological properties of integrin alpha v beta 3 on human melanoma cells, Cancer Metastasis Rev., 10, 3, 10.1007/BF00046839 Cooke, 2000, Contraction of collagen matrices mediated by alpha2beta1A and alpha(v)beta3 integrins, J. Cell Sci., 113, 2375, 10.1242/jcs.113.13.2375 Cooper, 2002, The role of alpha(v)beta(3) in prostate cancer progression, Neoplasia, 4, 191, 10.1038/sj.neo.7900224 Deryugina, 2001, MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells, Exp. Cell Res., 263, 209, 10.1006/excr.2000.5118 Di Nezza, 2002, Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion, Cancer, 94, 1466, 10.1002/cncr.10355 Egeblad, 2002, New functions for the matrix metalloproteinases in cancer progression, Nat. Rev., Cancer, 2, 161, 10.1038/nrc745 Fang, 1999, Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta, J. Immunol., 162, 5528, 10.4049/jimmunol.162.9.5528 Flores, 1996, Bone sialoprotein coated on glass and plastic surfaces is recognized by different beta 3 integrins, Exp. Cell Res., 227, 40, 10.1006/excr.1996.0247 Fridman, 1992, Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions, J. Biol. Chem., 267, 15398, 10.1016/S0021-9258(19)49547-1 Giancotti, 1999, Integrin signaling, Science, 285, 1028, 10.1126/science.285.5430.1028 Gilles, 1998, SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines, Cancer Res., 58, 5529 Haas, 1998, Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells, J. Biol. Chem., 273, 3604, 10.1074/jbc.273.6.3604 Hieken, 1996, Beta3 integrin expression in melanoma predicts subsequent metastasis, J. Surg. Res., 63, 169, 10.1006/jsre.1996.0242 Holmbeck, 1999, MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover, Cell, 99, 81, 10.1016/S0092-8674(00)80064-1 Horton, 1995, Interactions of connective tissue cells with the extracellular matrix, Bone, 17, 51S, 10.1016/8756-3282(95)00177-F Hotary, 2003, Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix, Cell, 114, 33, 10.1016/S0092-8674(03)00513-0 Humphries, 2000, Integrin structure, Biochem. Soc. Trans., 28, 311, 10.1042/0300-5127:0280311 Kumar, 2003, Integrin alpha v beta 3 as a therapeutic target for blocking tumor-induced angiogenesis, Curr. Drug Targets, 4, 123, 10.2174/1389450033346830 Lafleur, 2001, Perivascular cells regulate endothelial membrane type-1 matrix metalloproteinase activity, Biochem. Biophys. Res. Commun., 282, 463, 10.1006/bbrc.2001.4596 Lafleur, 2003, Selective involvement of TIMP-2 in the second activational cleavage of pro-MMP-2: refinement of the pro-MMP-2 activation mechanism, FEBS Lett., 553, 457, 10.1016/S0014-5793(03)01094-9 Lafleur, 2005, Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: a major induction of stromal MMP-13, Int. J. Cancer, 114, 544, 10.1002/ijc.20763 Lafleur, 2006, Type I collagen abrogates the clathrin-mediated internalization of membrane type 1 matrix metalloproteinase (MT1-MMP) via the MT1-MMP hemopexin domain, J. Biol. Chem., 281, 6826, 10.1074/jbc.M513084200 Lawler, 1989, An integrin receptor on normal and thrombasthenic platelets that binds thrombospondin, Blood, 74, 2022, 10.1182/blood.V74.6.2022.2022 Miller, 1994, Emergence of MCF-7 cells overexpressing a transfected epidermal growth factor receptor (EGFR) under estrogen-depleted conditions: evidence for a role of EGFR in breast cancer growth and progression, Cell Growth Differ., 5, 1263 Nemeth, 2002, Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis, J. Natl. Cancer Inst., 94, 17, 10.1093/jnci/94.1.17 Nguyen, 2000, Three-dimensional collagen matrices induce delayed but sustained activation of gelatinase A in human endothelial cells via MT1-MMP, Int. J. Biochem. Cell Biol., 32, 621, 10.1016/S1357-2725(00)00013-3 Nisato, 2005, Dissecting the role of matrix metalloproteinases (MMP) and integrin alpha(v)beta3 in angiogenesis in vitro: absence of hemopexin C domain bioactivity, but membrane-Type 1-MMP and alpha(v)beta3 are critical, Cancer Res., 65, 9377, 10.1158/0008-5472.CAN-05-1512 Oh, 2004, Mutations in two matrix metalloproteinase genes, MMP-2 and MT1-MMP, are synthetic lethal in mice, Oncogene, 23, 5041, 10.1038/sj.onc.1207688 Pecheur, 2002, Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone, FASEB J., 16, 1266, 10.1096/fj.01-0911fje Pereira, 2004, Bimolecular interaction of insulin-like growth factor (IGF) binding protein-2 with alphavbeta3 negatively modulates IGF-I-mediated migration and tumor growth, Cancer Res., 64, 977, 10.1158/0008-5472.CAN-03-3056 Ratnikov, 2002, An alternative processing of integrin alpha(v) subunit in tumor cells by membrane type-1 matrix metalloproteinase, J. Biol. Chem., 277, 7377, 10.1074/jbc.M109580200 Ria, 2002, Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 agree with progression of ovarian endometriomas, Eur. J. Clin. Invest., 32, 199, 10.1046/j.1365-2362.2002.00960.x Riikonen, 1995, Transforming growth factor-beta regulates collagen gel contraction by increasing alpha 2 beta 1 integrin expression in osteogenic cells, J. Biol. Chem., 270, 376, 10.1074/jbc.270.1.376 Rozanov, 2001, Mutation analysis of membrane type-1 matrix metalloproteinase (MT1-MMP). The role of the cytoplasmic tail Cys(574), the active site Glu(240), and furin cleavage motifs in oligomerization, processing, and self-proteolysis of MT1-MMP expressed in breast carcinoma cells, J. Biol. Chem., 276, 25705, 10.1074/jbc.M007921200 Ruangpanit, 2001, Gelatinase A (MMP-2) activation by skin fibroblasts: dependence on MT1-MMP expression and fibrillar collagen form, Matrix Biol., 20, 193, 10.1016/S0945-053X(01)00135-4 Soini, 2001, Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart, J. Pathol., 194, 225, 10.1002/path.850 Sounni, 2002, MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression, FASEB J., 16, 555, 10.1096/fj.01-0790com Stanton, 1998, The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form, J. Cell Sci., 111, 2789, 10.1242/jcs.111.18.2789 Stearns, 1996, Evidence for increased activated metalloproteinase 2 (MMP-2a) expression associated with human prostate cancer progression, Oncol. Res., 8, 69 Tam, 2002, Collagen binding properties of the membrane type-1 matrix metalloproteinase (MT1-MMP) hemopexin C domain. The ectodomain of the 44-kDa autocatalytic product of MT1-MMP inhibits cell invasion by disrupting native type I collagen cleavage, J. Biol. Chem., 277, 39005, 10.1074/jbc.M206874200 Thompson, 1994, Collagen induced MMP-2 activation in human breast cancer, Breast Cancer Res. Treat., 31, 357, 10.1007/BF00666168 Visse, 2003, Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry, Circ. Res., 92, 827, 10.1161/01.RES.0000070112.80711.3D Vonlaufen, 2001, Integrin alpha(v)beta(3) expression in colon carcinoma correlates with survival, Mod. Path., 14, 1126, 10.1038/modpathol.3880447 Wang, 2005, Beta3 integrins facilitate matrix interactions during transendothelial migration of PC3 prostate tumor cells, Prostate, 63, 65, 10.1002/pros.20168